Abel Hall LLC
RYTM icon

Abel Hall LLC’s Rhythm Pharmaceuticals RYTM Stock Holding History

Abel Hall LLC’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$403K Sell
4,230
-28
-0.7% -$2.99K 0.07% 292
2026
Q2 		$473K Buy
4,258
+243
+6% +$22K 0.08% 259
2026
Q1 		$349K Buy
4,015
+1,875
+88% +$182K 0.07% 335
2025
Q4 		$229K Buy
+2,140
New +$227K 0.05% 472

Other funds holding RYTM

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Mutual of America Capital Management
Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return
Wedge Capital Management
Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
Cannon Financial Strategists
Cannon Financial Strategists Athens, Georgia $885M AUM 13.17% 1-Year Est. Return
Exchange Traded Concepts
Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return
Aspiriant LLC
Aspiriant LLC Los Angeles, California $4.08B AUM 12.02% 1-Year Est. Return
Toth Financial Advisory
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
E. Ohman J:or Asset Management
E. Ohman J:or Asset Management Stockholm, Sweden $4.47B AUM 27.58% 1-Year Est. Return
Avior Wealth Management
Avior Wealth Management Omaha, Nebraska $3.79B AUM 15.36% 1-Year Est. Return

Abel Hall LLC's RYTM Position: Q3 2026 in Review

Abel Hall LLC reduced its Rhythm Pharmaceuticals (RYTM) stake by 0.66% in Q3 2026, selling an estimated $2.99K and leaving 4,230 shares worth $403K. The position accounts for 0.07% of the portfolio, ranked #292.

Abel Hall LLC first reported a position in RYTM in Q4 2025 and has held it in 4 quarters since. The position peaked at $473K in Q2 2026. 50 funds tracked by Wall St. Rank hold RYTM as of Q3 2026.

  • Abel Hall LLC held 4,230 shares of Rhythm Pharmaceuticals worth $403K as of Q3 2026.
  • Abel Hall LLC sold 28 Rhythm Pharmaceuticals shares in Q3 2026, an estimated $2.99K.
  • Rhythm Pharmaceuticals made up 0.07% of Abel Hall LLC's portfolio in Q3 2026, its #292 holding.
  • Abel Hall LLC first reported a position in Rhythm Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
  • Abel Hall LLC's Rhythm Pharmaceuticals position peaked at $473K in Q2 2026.
  • 50 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2026.

Based on Abel Hall LLC's 13F filing for Q3 2026, filed 19 Oct 2026.